Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharmagar AB
AB
In liquidation
Org 5567792931
Business and other management consultancy activities · NACE 7022
Est. 2009
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2020
SEK 0
EBITDA margin
—
-50% vs 2019
Equity ratio
94.5%
Financial strength
Net profit 2020
SEK 166K
+2867% vs 2019
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
SEK 0
—
EBITDA
SEK -9K
-50%
Net profit
SEK 166K
+2867%
Total assets
SEK 812K
-16%
Equity
SEK 767K
-20%
Employees
0
—
Company information
Legal name
Pharmagar AB
Org number
5567792931
Legal form
Aktiebolag
NACE code
7022 · Business and other management consultancy activities
Founded
10 mars 2009
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-08-31
Financial year
January – December
Company purpose
Klinisk och farmacevtisk konsultverksamhet
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
Income statement
SEK thousands
Item
2016
2017
2018
2019
2020
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−6
−6
−6
−6
−9
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−6
−6
−6
−6
−9
Net financials
39
—
23
—
219
Profit before tax
217
58
17
−6
210
Tax
−48
−13
−4
−0
−44
Net profit
169
45
13
−6
166
Balance sheet
SEK thousands
Item
2016
2017
2018
2019
2020
Total assets
1 552
1 352
1 158
968
812
Equity
1 394
1 283
1 133
958
767
Long-term debt
0
0
0
0
0
Short-term debt
94
69
24
10
45
Total debt
94
69
24
10
45
Financial ratios
5-year trend
EBITDA margin
-900000.0%
This company
15.8%
Market median
-5696303% vs market
2016
2020
Equity ratio
94.5%
This company
38.2%
Market median
+147% vs market
2016
2020
Return on equity
21.6%
This company
18.4%
Market median
+17% vs market
2016
2020
Net profit margin
16600000.0%
This company
8.1%
Market median
+204938172% vs market
2016
2020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2016
2020
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2016
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KR
Kent Roger Antonsson
Liquidator
Liquidator
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
PA
Per Arne Friberg
Deputy Board Member
2020 – 2021
AK
Agneta Kristin Gelin Friberg
Board of Directors
2020 – 2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pharmagar AB also hold positions in
0
other companies.
Person
Role here
Other companies
Kent Roger Antonsson
Liquidator
0 companies
Per Arne Friberg
Deputy Board Member
0 companies
Agneta Kristin Gelin Friberg
Board of Directors
0 companies